{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:30:27Z","timestamp":1775784627869,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972845"],"award-info":[{"award-number":["81972845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013280","name":"Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["24KJA320009"],"award-info":[{"award-number":["24KJA320009"]}],"id":[{"id":"10.13039\/501100013280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06594-0","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:18:54Z","timestamp":1748362734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ATP11B triggers the infiltration of T cells into GBM and intensifies anti-GBM immunity by upregulating and externalizing S1PR1"],"prefix":"10.1186","volume":"23","author":[{"given":"Hui","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyijie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-5292","authenticated-orcid":false,"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"6","key":"6594_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/WCO.0000000000000988","volume":"34","author":"JA Jansen","year":"2021","unstructured":"Jansen JA, Omuro A, Lucca LE. T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies. Curr Opin Neurol. 2021;34(6):827\u201333. https:\/\/doi.org\/10.1097\/WCO.0000000000000988","journal-title":"Curr Opin Neurol"},{"issue":"9","key":"6594_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","volume":"24","author":"P Chongsathidkiet","year":"2018","unstructured":"Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med. 2018;24(9):1459\u201368. https:\/\/doi.org\/10.1038\/s41591-018-0135-2","journal-title":"Nat Med"},{"issue":"9","key":"6594_CR3","doi-asserted-by":"publisher","first-page":"e2204961","DOI":"10.1002\/advs.202204961","volume":"10","author":"T Wang","year":"2023","unstructured":"Wang T, Zhang H, Han Y, Zheng Q, Liu H, Han M, Li Z. Reversing T cell dysfunction to boost glioblastoma immunotherapy by Paroxetine-Mediated GRK2 Inhibition and Blockade of multiple checkpoints through biomimetic nanoparticles. Adv Sci (Weinh). 2023;10(9):e2204961. https:\/\/doi.org\/10.1002\/advs.202204961","journal-title":"Adv Sci (Weinh)"},{"key":"6594_CR4","doi-asserted-by":"publisher","unstructured":"Dixit D, Hallisey VM, Zhu EY, Okuniewska M, Cadwell K, Chipuk JE, Axelrad JE, Schwab SR. S1PR1 Inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes. J Clin Invest. 2024;134(4). https:\/\/doi.org\/10.1172\/JCI174984","DOI":"10.1172\/JCI174984"},{"issue":"11","key":"6594_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41423-022-00921-x","volume":"19","author":"L Tian","year":"2022","unstructured":"Tian L, Wu Y, Choi HJ, Sui X, Li X, Sofi MH, Kassir MF, Chen X, Mehrotra S, Ogretmen B, Yu XZ. S1P\/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission. Cell Mol Immunol. 2022;19(11):1235\u201350. https:\/\/doi.org\/10.1038\/s41423-022-00921-x","journal-title":"Cell Mol Immunol"},{"key":"6594_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fphys.2016.00275","volume":"7","author":"JP Andersen","year":"2016","unstructured":"Andersen JP, Vestergaard AL, Mikkelsen SA, Mogensen LS, Chalat M, Molday RS. P4-ATPases as phospholipid Flippases-Structure, function, and enigmas. Front Physiol. 2016;7:275. https:\/\/doi.org\/10.3389\/fphys.2016.00275","journal-title":"Front Physiol"},{"key":"6594_CR7","doi-asserted-by":"publisher","unstructured":"Xu J, Su SM, Zhang X, Chan UI, Adhav R, Shu X, Liu J, Li J, Mo L, Wang Y, An T, Lei JH, Miao K, Deng CX, Xu X. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine. J Clin Invest. 2022;132(5). https:\/\/doi.org\/10.1172\/JCI149473","DOI":"10.1172\/JCI149473"},{"key":"6594_CR8","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhang S, Zhao X, Wu P, Ying Y, Wu L, Zhuang J, Chen Z, Chao Y, Dong X, Zhao RC, Wang J. ATP11B Modulates Microglial Lipid Metabolism and Alleviates Alzheimer\u2019s Disease Pathology. MedComm (2020). 2025;6(4):e70139. https:\/\/doi.org\/10.1002\/mco2.70139","DOI":"10.1002\/mco2.70139"},{"issue":"1","key":"6594_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12964-025-02090-6","volume":"23","author":"R Pulica","year":"2025","unstructured":"Pulica R, Aquib A, Varsanyi C, Gadiyar V, Wang Z, Frederick T, Calianese DC, Patel B, de Dios KV, Poalasin V, De Lorenzo MS, Kotenko SV, Wu Y, Yang A, Choudhary A, Sriram G, Birge RB. Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer. Cell Commun Signal. 2025;23(1):131. https:\/\/doi.org\/10.1186\/s12964-025-02090-6","journal-title":"Cell Commun Signal"},{"key":"6594_CR10","doi-asserted-by":"publisher","first-page":"114861","DOI":"10.1016\/j.addr.2023.114861","volume":"197","author":"P Khare","year":"2023","unstructured":"Khare P, Edgecomb SX, Hamadani CM, Tanner EEL. Lipid nanoparticle-mediated drug delivery to the brain. Adv Drug Deliv Rev. 2023;197:114861. https:\/\/doi.org\/10.1016\/j.addr.2023.114861","journal-title":"Adv Drug Deliv Rev"},{"issue":"26","key":"6594_CR11","doi-asserted-by":"publisher","first-page":"e2313226","DOI":"10.1002\/adma.202313226","volume":"36","author":"AE Metzloff","year":"2024","unstructured":"Metzloff AE, Padilla MS, Gong N, Billingsley MM, Han X, Merolle M, Mai D, Figueroa-Espada CG, Thatte AS, Haley RM, Mukalel AJ, Hamilton AG, Alameh MG, Weissman D, Sheppard NC, June CH, Mitchell MJ. Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell Cancer immunotherapy. Adv Mater. 2024;36(26):e2313226. https:\/\/doi.org\/10.1002\/adma.202313226","journal-title":"Adv Mater"},{"key":"6594_CR12","doi-asserted-by":"publisher","first-page":"121339","DOI":"10.1016\/j.biomaterials.2021.121339","volume":"281","author":"A Kheirolomoom","year":"2022","unstructured":"Kheirolomoom A, Kare AJ, Ingham ES, Paulmurugan R, Robinson ER, Baikoghli M, Inayathullah M, Seo JW, Wang J, Fite BZ, Wu B, Tumbale SK, Raie MN, Cheng RH, Nichols L, Borowsky AD, Ferrara KW. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials. 2022;281:121339. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121339","journal-title":"Biomaterials"},{"issue":"13","key":"6594_CR13","doi-asserted-by":"publisher","first-page":"e2319856121","DOI":"10.1073\/pnas.2319856121","volume":"121","author":"CM Tilsed","year":"2024","unstructured":"Tilsed CM, Sadiq BA, Papp TE, Areesawangkit P, Kimura K, Noguera-Ortega E, Scholler J, Cerda N, Aghajanian H, Bot A, Mui B, Tam Y, Weissman D, June CH, Albelda SM, Parhiz H. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation. Proc Natl Acad Sci U S A. 2024;121(13):e2319856121. https:\/\/doi.org\/10.1073\/pnas.2319856121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6594_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jconrel.2022.08.033","volume":"350","author":"JE Zhou","year":"2022","unstructured":"Zhou JE, Sun L, Jia Y, Wang Z, Luo T, Tan J, Fang X, Zhu H, Wang J, Yu L, Yan Z. Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo. J Control Release. 2022;350:298\u2013307. https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.033","journal-title":"J Control Release"},{"key":"6594_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186034","author":"L Pang","year":"2025","unstructured":"Pang L, Guo S, Huang Y, Khan F, Liu Y, Zhou F, Lathia JD, Chen P. Targeting legumain-mediated cell-cell interaction sensitizes glioblastoma to immunotherapy in preclinical models. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI186034","journal-title":"J Clin Invest"},{"key":"6594_CR16","doi-asserted-by":"publisher","first-page":"104649","DOI":"10.1016\/j.critrevonc.2025.104649","volume":"208","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zhang M, Wang G, Lai W, Liao S, Chen Y, Ning Q, Tang S. Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia\/macrophages: from basic insights to therapeutic strategies. Crit Rev Oncol Hematol. 2025;208:104649. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104649","journal-title":"Crit Rev Oncol Hematol"},{"key":"6594_CR17","doi-asserted-by":"publisher","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133(1). https:\/\/doi.org\/10.1172\/JCI163446","DOI":"10.1172\/JCI163446"},{"issue":"22","key":"6594_CR18","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-23-0576","volume":"29","author":"V Fermi","year":"2023","unstructured":"Fermi V, Warta R, Wollner A, Lotsch C, Jassowicz L, Rapp C, Knoll M, Jungwirth G, Jungk C, Dao Trong P, von Deimling A, Abdollahi A, Unterberg A, Herold-Mende C. Effective reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated microglia\/macrophages by treatment with GW2580. Clin Cancer Res. 2023;29(22):4685\u201397. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0576","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6594_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13578-024-01231-7","volume":"14","author":"Y Deng","year":"2024","unstructured":"Deng Y, Chen Q, Wan C, Sun Y, Huang F, Hu Y, Yang K. Microglia and macrophage metabolism: a regulator of cerebral gliomas. Cell Biosci. 2024;14(1):49. https:\/\/doi.org\/10.1186\/s13578-024-01231-7","journal-title":"Cell Biosci"},{"issue":"1","key":"6594_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","volume":"14","author":"S Zhou","year":"2023","unstructured":"Zhou S, Huang Y, Chen Y, Liu Y, Xie L, You Y, Tong S, Xu J, Jiang G, Song Q, Mei N, Ma F, Gao X, Chen H, Chen J. Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma. Nat Commun. 2023;14(1):435. https:\/\/doi.org\/10.1038\/s41467-023-35957-8","journal-title":"Nat Commun"},{"issue":"1","key":"6594_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kuckelhaus J, Vollmer L, Goeldner JM, Behringer SP, Scherer F, Boerries M, Follo M, Weiss T, Delev D, Kernbach J, Franco P, Schallner N, Dierks C, Carro MS, Hofmann UG, Fung C, Sankowski R, Prinz M, Beck J, Salie H, Bengsch B, Schnell O, Heiland DH. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13(1):925. https:\/\/doi.org\/10.1038\/s41467-022-28523-1","journal-title":"Nat Commun"},{"key":"6594_CR22","doi-asserted-by":"publisher","unstructured":"Saidakova EV. Lymphopenia and Mechanisms of T-Cell Regeneration. Cell tissue biol. 2022;16(4):302\u2013\u200911. https:\/\/doi.org\/10.1134\/S1990519X2204006X","DOI":"10.1134\/S1990519X2204006X"},{"issue":"1","key":"6594_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, Hsu JL, Chou CW, Sun X, Deng Y, Chou CK, Yu D, Hung MC. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. 2021;12(1):832. https:\/\/doi.org\/10.1038\/s41467-021-21099-2","journal-title":"Nat Commun"},{"issue":"7","key":"6594_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.celrep.2019.07.044","volume":"28","author":"P Chakraborty","year":"2019","unstructured":"Chakraborty P, Vaena SG, Thyagarajan K, Chatterjee S, Al-Khami A, Selvam SP, Nguyen H, Kang I, Wyatt MW, Baliga U, Hedley Z, Ngang RN, Guo B, Beeson GC, Husain S, Paulos CM, Beeson CC, Zilliox MJ, Hill EG, Mehrotra M, Yu XZ, Ogretmen B, Mehrotra S. Pro-Survival lipid Sphingosine-1-Phosphate metabolically programs T cells to limit Anti-tumor activity. Cell Rep. 2019;28(7):1879\u2013e937. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.044","journal-title":"Cell Rep"},{"key":"6594_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13963","author":"T Nakano","year":"2025","unstructured":"Nakano T, Okita K, Okazaki S, Yoshimoto S, Masuko S, Yagi H, Kato K, Tomioka Y, Imai K, Hamada Y, Masuko K, Shimada-Takaura K, Nagai N, Saya H, Arai T, Ishiwata T, Masuko T. CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb. FEBS Open Bio. 2025. https:\/\/doi.org\/10.1002\/2211-5463.13963","journal-title":"FEBS Open Bio"},{"key":"6594_CR26","doi-asserted-by":"publisher","first-page":"217158","DOI":"10.1016\/j.canlet.2024.217158","volume":"600","author":"YQ Wang","year":"2024","unstructured":"Wang YQ, Ren Y, Gale RP, Niu LT, Huang XJ. Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells. Cancer Lett. 2024;600:217158. https:\/\/doi.org\/10.1016\/j.canlet.2024.217158","journal-title":"Cancer Lett"},{"issue":"47","key":"6594_CR27","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41388-023-02853-w","volume":"42","author":"YP Tao","year":"2023","unstructured":"Tao YP, Zhu HY, Shi QY, Wang CX, Hua YX, Hu HY, Zhou QY, Zhou ZL, Sun Y, Wang XM, Wang Y, Zhang YL, Guo YJ, Wang ZY, Che X, Xu CW, Zhang XC, Heger M, Tao SP, Zheng X, Xu Y, Ao L, Liu AJ, Liu SB, Cheng SQ, Pan WW. S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1\/2-YAP pathway. Oncogene. 2023;42(47):3491\u2013502. https:\/\/doi.org\/10.1038\/s41388-023-02853-w","journal-title":"Oncogene"},{"key":"6594_CR28","doi-asserted-by":"publisher","unstructured":"Tang T, Huang X, Zhang G, Lu M, Hong Z, Wang M, Huang J, Zhi X, Liang T. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. J Immunother Cancer. 2022;10(3). https:\/\/doi.org\/10.1136\/jitc-2021-004129","DOI":"10.1136\/jitc-2021-004129"},{"issue":"1","key":"6594_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-024-03058-z","volume":"43","author":"N Dong","year":"2024","unstructured":"Dong N, Qi W, Wu L, Li J, Zhang X, Wu H, Zhang W, Jiang J, Zhang S, Fu W, Liu Q, Qi G, Wang L, Lu Y, Luo J, Kong Y, Liu Y, Zhao RC, Wang J. LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B. J Exp Clin Cancer Res. 2024;43(1):139. https:\/\/doi.org\/10.1186\/s13046-024-03058-z","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6594_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12672-025-02241-8","volume":"16","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zeng L, Zeng F, Huang Y, Jia L. Bioinformatics exploration of the S1PR1 receptor in various human cancers and its clinical relevance. Discov Oncol. 2025;16(1):449. https:\/\/doi.org\/10.1007\/s12672-025-02241-8","journal-title":"Discov Oncol"},{"issue":"6","key":"6594_CR31","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.7150\/thno.88864","volume":"14","author":"K Onyshchenko","year":"2024","unstructured":"Onyshchenko K, Luo R, Rao X, Zhang X, Gaedicke S, Grosu AL, Firat E, Niedermann G. Hypofractionated radiotherapy combined with Lenalidomide improves systemic antitumor activity in mouse solid tumor models. Theranostics. 2024;14(6):2573\u201388. https:\/\/doi.org\/10.7150\/thno.88864","journal-title":"Theranostics"},{"issue":"11","key":"6594_CR32","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41416-023-02230-0","volume":"128","author":"L Mao","year":"2023","unstructured":"Mao L, Zhou JJ, Xiao Y, Yang QC, Yang SC, Wang S, Wu ZZ, Xiong HG, Yu HJ, Sun ZJ. Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner. Br J Cancer. 2023;128(11):2126\u201339. https:\/\/doi.org\/10.1038\/s41416-023-02230-0","journal-title":"Br J Cancer"},{"key":"6594_CR33","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.neo.2024.101099","volume":"60","author":"L Ma","year":"2025","unstructured":"Ma L, Li Y, Sakamoto Y, Xie L, Suzuki S, Yoshida Y, Sui L, Guo G, Wen J, Ren W, Kakimi K, Osada K, Takahashi A, Shimokawa T. Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody. Neoplasia. 2025;60:101099. https:\/\/doi.org\/10.1016\/j.neo.2024.101099","journal-title":"Neoplasia"},{"issue":"24","key":"6594_CR34","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1182\/bloodadvances.2024012599","volume":"8","author":"N Kostopoulos","year":"2024","unstructured":"Kostopoulos N, Costabile F, Krimitza E, Beghi S, Goia D, Perales-Linares R, Thyfronitis G, LaRiviere MJ, Chong EA, Schuster SJ, Maity A, Koumenis C, Plastaras JP, Facciabene A. Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration. Blood Adv. 2024;8(24):6308\u201320. https:\/\/doi.org\/10.1182\/bloodadvances.2024012599","journal-title":"Blood Adv"},{"issue":"1","key":"6594_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","volume":"11","author":"Y Liu","year":"2018","unstructured":"Liu Y, Dong Y, Kong L, Shi F, Zhu H, Yu J. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors. J Hematol Oncol. 2018;11(1):104. https:\/\/doi.org\/10.1186\/s13045-018-0647-8","journal-title":"J Hematol Oncol"},{"issue":"2","key":"6594_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/1744666X.2024.2412770","volume":"21","author":"M Nisnboym","year":"2025","unstructured":"Nisnboym M, Sneiderman CT, Jaswal AP, Xiong Z, Vincze SR, Sever RE, Zou H, Frederico SC, Agnihotri S, Hu B, Drappatz J, Pollack IF, Kohanbash G, Raphael I. Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM. Expert Rev Clin Immunol. 2025;21(2):239\u201347. https:\/\/doi.org\/10.1080\/1744666X.2024.2412770","journal-title":"Expert Rev Clin Immunol"},{"key":"6594_CR37","doi-asserted-by":"publisher","unstructured":"Chen H, Qin Y, Chou M, Cyster JG, Li X. Transmembrane protein CD69 acts as an S1PR1 agonist. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.88204","DOI":"10.7554\/eLife.88204"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06594-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:18:55Z","timestamp":1748362735000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6594"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06594-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving animals were in compliance with the guidelines of Jiangsu Council on Animal Care, and ethical approval was granted by the animal ethics committee of Xuzhou Medical University of China (No: 202210S005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}